|
SG11201600853UA
(en)
|
2013-08-05 |
2016-03-30 |
Twist Bioscience Corp |
De novo synthesized gene libraries
|
|
CA2975852A1
(en)
|
2015-02-04 |
2016-08-11 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
EA201890763A1
(ru)
|
2015-09-18 |
2018-08-31 |
Твист Байосайенс Корпорейшн |
Библиотеки вариантных олигонуклеиновых кислот и их синтез
|
|
KR102794025B1
(ko)
|
2015-09-22 |
2025-04-09 |
트위스트 바이오사이언스 코포레이션 |
핵산 합성을 위한 가요성 기판
|
|
WO2017095958A1
(en)
|
2015-12-01 |
2017-06-08 |
Twist Bioscience Corporation |
Functionalized surfaces and preparation thereof
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
CR20220248A
(es)
|
2016-03-16 |
2022-07-18 |
Immatics Biotechnologies Gmbh |
Células t transfectadas y receptores de células t de utilidad en inmunoterapias contra el cáncer
|
|
WO2018038772A1
(en)
|
2016-08-22 |
2018-03-01 |
Twist Bioscience Corporation |
De novo synthesized nucleic acid libraries
|
|
EP3516528B1
(en)
|
2016-09-21 |
2025-10-15 |
Atlas Data Storage, Inc. |
Nucleic acid based data storage
|
|
MD3551221T2
(ro)
|
2016-12-08 |
2022-04-30 |
Immatics Biotechnologies Gmbh |
Noi receptori de celule T și imunoterapie cu utilizarea acestora
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
GB2573069A
(en)
*
|
2016-12-16 |
2019-10-23 |
Twist Bioscience Corp |
Variant libraries of the immunological synapse and synthesis thereof
|
|
JP2020508661A
(ja)
|
2017-02-22 |
2020-03-26 |
ツイスト バイオサイエンス コーポレーション |
核酸ベースのデータ保存
|
|
CN110913865A
(zh)
|
2017-03-15 |
2020-03-24 |
特韦斯特生物科学公司 |
免疫突触的变体文库及其合成
|
|
SG10202107869QA
(en)
*
|
2017-04-10 |
2021-08-30 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
SG11201912057RA
(en)
|
2017-06-12 |
2020-01-30 |
Twist Bioscience Corp |
Methods for seamless nucleic acid assembly
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
CN111566125A
(zh)
|
2017-09-11 |
2020-08-21 |
特韦斯特生物科学公司 |
Gpcr结合蛋白及其合成
|
|
EP3691662A4
(en)
*
|
2017-10-06 |
2021-05-12 |
The University of Chicago |
Screening of t lymphocytes for cancer-specific antigens
|
|
US12178787B2
(en)
|
2017-10-12 |
2024-12-31 |
Board Of Regents, The University Of Texas System |
T cell receptors for immunotherapy
|
|
KR102637566B1
(ko)
|
2017-10-20 |
2024-02-16 |
트위스트 바이오사이언스 코포레이션 |
폴리뉴클레오타이드 합성을 위한 가열된 나노웰
|
|
CN112041438B
(zh)
|
2018-01-04 |
2025-05-23 |
特韦斯特生物科学公司 |
基于dna的数字信息存储
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
CN118957038A
(zh)
|
2018-05-18 |
2024-11-15 |
特韦斯特生物科学公司 |
用于核酸杂交的多核苷酸、试剂和方法
|
|
US20210317184A1
(en)
*
|
2018-09-05 |
2021-10-14 |
GlaxoSmithKline Intellectual Property Devolopment Limited |
T cell modification
|
|
JP7528058B2
(ja)
*
|
2018-09-14 |
2024-08-05 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Ｔｃｒリガンドの高スループットペプチド－ｍｈｃ親和性スクリーニングのための方法
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
CA3124980A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
WO2020176680A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
JP2022521551A
(ja)
|
2019-02-26 |
2022-04-08 |
ツイスト バイオサイエンス コーポレーション |
Ｇｌｐ１受容体の変異体核酸ライブラリ
|
|
US20200297768A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
EA202193074A1
(ru)
*
|
2019-05-08 |
2022-03-21 |
Медиджин Иммунотерапис Гмбх |
Сконструированные т-клетки
|
|
AU2020283500A1
(en)
|
2019-05-27 |
2022-01-27 |
Immatics US, Inc. |
Viral vectors and their use in adoptive cellular therapy
|
|
MX2021015946A
(es)
*
|
2019-06-18 |
2022-04-18 |
Regeneron Pharma |
Receptores de linfocitos t de mage-a4 y métodos de uso de estos.
|
|
CA3144054A1
(en)
*
|
2019-06-20 |
2020-12-24 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
WO2020257612A1
(en)
|
2019-06-21 |
2020-12-24 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
EP4004033A4
(en)
*
|
2019-07-30 |
2023-12-06 |
University Health Network |
MHC CLASS II MOLECULES AND METHODS OF USE
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
JP2022548783A
(ja)
|
2019-09-23 |
2022-11-21 |
ツイスト バイオサイエンス コーポレーション |
単一ドメイン抗体のバリアント核酸ライブラリー
|
|
WO2021061829A1
(en)
|
2019-09-23 |
2021-04-01 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for crth2
|
|
CN115279389A
(zh)
*
|
2020-01-06 |
2022-11-01 |
纪念斯隆-凯特琳癌症中心 |
新型显性负性Fas多肽、包含其的细胞及其用途
|
|
AU2021225817A1
(en)
|
2020-02-24 |
2022-10-20 |
Immatics US, Inc. |
Methods for expanding T cells for the treatment of cancer and related malignancies
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
US20220056411A1
(en)
*
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
KR102587454B1
(ko)
*
|
2020-10-07 |
2023-10-11 |
주식회사 다안바이오테라퓨틱스 |
T 세포 수용체, t 세포 수용체를 포함하는 면역 세포 및 이를 이용하는 방법
|
|
KR20230135589A
(ko)
|
2020-12-31 |
2023-09-25 |
이매틱스 유에스 인코포레이티드 |
Cd8 폴리펩타이드, 조성물 및 이의 사용 방법
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
WO2022225836A1
(en)
*
|
2021-04-21 |
2022-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
KR20240004937A
(ko)
|
2021-05-05 |
2024-01-11 |
이매틱스 바이오테크놀로지스 게엠베하 |
Bma031 항원 결합 폴리펩타이드
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
TW202332765A
(zh)
|
2021-09-20 |
2023-08-16 |
美商英麥提克斯股份有限公司 |
用於ｔ細胞療法之ｔ細胞群體的單核球耗盡
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
CA3236646A1
(en)
*
|
2021-11-03 |
2023-05-11 |
Ji Wang |
Novel anti-l1cam antibody
|
|
WO2023081461A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
EP4448108A1
(en)
|
2021-11-08 |
2024-10-23 |
Immatics Biotechnologies GmbH |
Adoptive cell therapy combination treatment and compositions thereof
|
|
CA3247927A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics Inc |
Compositions, systems and methods for programming T-lymphocyte phenotypes by targeted gene repression
|
|
WO2023137471A1
(en)
|
2022-01-14 |
2023-07-20 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
WO2023148494A1
(en)
*
|
2022-02-03 |
2023-08-10 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
JP2025515604A
(ja)
|
2022-04-28 |
2025-05-20 |
イマティクス ユーエス，アイエヌシー． |
ドミナントネガティブＴＧＦβ受容体ポリペプチド、ＣＤ８ポリペプチド、細胞、組成物、およびその使用方法
|
|
US20230348548A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
US20240066127A1
(en)
|
2022-04-28 |
2024-02-29 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
WO2023215825A1
(en)
|
2022-05-05 |
2023-11-09 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
CN119698428A
(zh)
*
|
2022-06-24 |
2025-03-25 |
安进公司 |
Magea4特异性t细胞受体
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
JP2025531268A
(ja)
|
2022-09-19 |
2025-09-19 |
チューン セラピューティクス インコーポレイテッド |
Ｔ細胞機能を調節するための組成物、システム、および方法
|
|
WO2025029835A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating il-2 gene expression
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
US20250134931A1
(en)
|
2023-11-01 |
2025-05-01 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233420A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use of anti-cancer molecules
|